Orchestra BioMed Holdings Target Price

See Orchestra BioMed Holdings's analyst price targets ($10) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$6.15

Average Target Price

$10.00

62.6% upside

3 analysts in the last 4 months

High: $10 | Low: $10

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-10-05	H.C. WainwrightYi Chen	$10	62.6% upside
2026-09-10	BTIGMarie Thibault	$10	62.6% upside
2026-08-11	Piper SandlerMatt O'Brien	$10	62.6% upside
2026-05-13	BarclaysMatt Miksic	$13	111.4% upside
2026-01-09	BarclaysMatt Miksic	$12	95.1% upside
2025-03-20	BTIGMarie Thibault	$12	95.1% upside

Orchestra BioMed Holdings (OBIO) FAQ

Orchestra BioMed Holdings posts a target price of $10. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $10 for OBIO means covering analysts, on average, see the stock 62.6% upside of $6.15 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for OBIO's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Orchestra BioMed Holdings's other metric pages and overview cover the third.